Clinical Trials · NCT04199728
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Milton S. Hershey Medical Center
- Enrollment
- 27
- Start date
- Oct 2021
- Locations
- 1 site, United States
- Primary endpoint
- Change in Self-reported Cue-elicited Drug Craving as Measured by Visual Analog Scale (VAS)